Partners

AMCARE will assess the possibility of making advanced biomaterial based therapeutics a central part of the treatment strategy for acute-MI patients in Europe in the future. This goal will be pursued by integrating numerous areas of materials science and stem cell biology within our multidisciplinary AMCARE consortium, composed of leaders with a unique combination of complementary expertise of leaders in the fields of: